These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8714614)

  • 1. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 2. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS; Hakimian D
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
    Schirmer M; Michlmayr G; Geisen F; Konwalinka G
    Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
    [No Abstract]   [Full Text] [Related]  

  • 4. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Delannoy A; Hanique G; Ferrant A
    N Engl J Med; 1993 Mar; 328(11):812; author reply 813. PubMed ID: 8094888
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Jun; 330(25):1829-30. PubMed ID: 7910665
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
    Cheson BD
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):14-21. PubMed ID: 9685175
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Juliusson G; Liliemark J
    N Engl J Med; 1994 Jun; 330(25):1828-9; author reply 1829-30. PubMed ID: 7910664
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs in the treatment of chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Robertson L; Plunkett W; Kantarjian H; Koller C
    Leukemia; 1992 Nov; 6 Suppl 4():140-1. PubMed ID: 1359203
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
    Vick DJ; Byrd JC; Beal CL; Chaffin DJ
    Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a place for 2-CDA in the treatment of B-CLL?
    Mitterbauer M; Hilgenfeld E; Wilfing A; Jäger U; Knauf WU
    Leukemia; 1997 Apr; 11 Suppl 2():S35-7. PubMed ID: 9178836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
    Krykowski E; Warzocha K; Robak T
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A; Lemon RH; Piro LD
    N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 17. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fludarabine and fatal hemolytic anemia].
    López L; del Villar V; Pascual T
    Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
    Smolej L
    Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hematologic remission and disappearance of hemolytic anemia in chronic lymphocytic leukemia after therapy with 2-chlorodeoxyadenosine (2-CDA)].
    Piatkowska-Jakubas B; Skotnicki AB
    Acta Haematol Pol; 1993; 24(3):289-93. PubMed ID: 7902636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.